CA Patent

CA3250302A1 — A pharmaceutical combination of antispasmodic and anxiolytic agent

Assigned to Drotastar LLC · Expires 2023-08-17 · 3y expired

What this patent protects

The present disclosure provides fixed dose combinations of Drotaverine or a salt thereof and benzodiazepines, methods of preparing fixed dose combinations, and their use in treatment.

USPTO Abstract

The present disclosure provides fixed dose combinations of Drotaverine or a salt thereof and benzodiazepines, methods of preparing fixed dose combinations, and their use in treatment.

Drugs covered by this patent

Patent Metadata

Patent number
CA3250302A1
Jurisdiction
CA
Classification
—
Expires
2023-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Drotastar LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.